XM không cung cấp dịch vụ cho cư dân của Mỹ.
T
T

ThermoFisher


Tin tức

Waters Corp raises annual profit forecast on higher demand for lab equipment

Waters Corp raises annual profit forecast on higher demand for lab equipment Nov 1 (Reuters) - Waters Corp WAT.N raised its annual profit forecast after beating Wall Street estimates for third-quarter profit and revenue on Friday, on improved demand for its products and services used in drug development and research. The lab equipment and software maker expects its 2024 adjusted profit to be between $11.67 and $11.87 per share, compared with its prior forecast of $11.55 to $11.65 per share.
T
W

Bio-Rad Laboratories beats quarterly profit estimates on strong sales in diagnostics unit

Bio-Rad Laboratories beats quarterly profit estimates on strong sales in diagnostics unit Oct 30 (Reuters) - Diagnostics firm Bio-Rad Laboratories BIO.N posted third-quarter profit above Wall Street estimates on Wednesday , helped by a recovery in demand for analytical tools from its biotech clients and steady clinical diagnostics products sales growth.
T

Bio-Techne beats quarterly profit estimates, driven by diagnostic unit growth; shares rise

Bio-Techne beats quarterly profit estimates, driven by diagnostic unit growth; shares rise Oct 30 (Reuters) - Bio-Techne TECH.O beat first-quarter profit estimates on Wednesday helped by growth in its diagnostics and spatial biology segment, sending the shares of the biotech company up 4.59% in premarket trading. On an adjusted basis, the Minnesota-based company posted a profit of 42 cents per share, surpassing the estimates of 38 cents per share, according to data collected by LSEG.
T

U.S. Coca-Cola, Nextera Energy Partners, ServiceNow

U.S. RESEARCH ROUNDUP-Coca-Cola, Nextera Energy Partners, ServiceNow Oct 24 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Coca-Cola, Nextera Energy Partners, and ServiceNow on Thursday. HIGHLIGHTS * Avery Dennison Corp AVY.N : JP Morgan cuts to neutral from overweight * Coca-Cola Co KO.N : JP Morgan cuts target price to $75 from $78 * Nextera Energy Partners LP NEP.N : JP Morgan raises to neutral from underweight *
A
A
A
B
C
D
D
E
E
N
R
C
L
T
E
E
I
S
T
A
A
E
E
G
H
L
R

U.S. STOCKS Apple, Hershey, Dow

BUZZ-U.S. STOCKS ON THE MOVE-Apple, Hershey, Dow Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes fell on Wednesday as worries of a less dovish Federal Reserve lifted Treasury yields, pressuring megacap stocks and amplifying losses in McDonald's and Coca-Cola shares.
A
A
B
N
N
Q
S
T
W
C
T
U
U
D
T
A
A

U.S. STOCKS Magnite, Nvidia, Tesla

BUZZ-U.S. STOCKS ON THE MOVE-Magnite, Nvidia, Tesla Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes moved lower on Wednesday, as worries of a less dovish Federal Reserve lifted Treasury yields, while losses in McDonald's and Coca-Cola also weighed on investors' minds.
A
B
I
N
N
Q
S
S
T
W
C
T
U
U
T
A
A
P

Thermo Fisher Says China Government's Stimulus And Loan Programs Affects The Industry In A Positive Way

BRIEF-Thermo Fisher Says China Government's Stimulus And Loan Programs Affects The Industry In A Positive Way Oct 23 (Reuters) - Thermo Fisher Scientific Inc TMO.N : THERMO FISHER EXEC SAYS COMPANY IS WELL-POSITIONED TO CAPITALIZE ON THE MARKET OPPORTUNITIES IN CHINA WHEN THE ECONOMY PICKS UP IN THE COUNTRY - CONF CALL THERMO FISHER EXEC SAYS CHINA
T

Thermo Fisher Scientific Inc reports results for the quarter ended in September 30 - Earnings Summary

Thermo Fisher Scientific Inc reports results for the quarter ended in September 30 - Earnings Summary Thermo Fisher Scientific Inc TMO.N reported quarterly adjusted earnings of $5.28​​ per share for the quarter ended September 30, lower than the same quarter last year, when the company reported EPS of $5.69. The mean expectation of twenty four analysts for the quarter was for earnings of $5.25 per share.
T

U.S. STOCKS Coca-Cola, Spirit Airlines, Boeing

BUZZ-U.S. STOCKS ON THE MOVE-Coca-Cola, Spirit Airlines, Boeing Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock index futures signaled another lower open on Wednesday as Treasury yields ticked up, fueled by concerns of a potentially less dovish central bank, while investors focused on earnings from companies including Coca-Cola and Starbucks.
A
B
I
Q
S
C
T
U
T
A
A

Thermo Fisher falls after Q3 revenue miss

BUZZ-Thermo Fisher falls after Q3 revenue miss ** Life sciences firm Thermo Fisher Scientific's TMO.N shares fall 2.1% to $574 premarket ** Company's Q3 revenue of $10.60 bln misses est of $10.64 bln - LSEG ** TMO forecasts annual adj profit between $21.35 and $22.07 per share, midpoint of which is slightly below est of $21.72 ** Company reports qu
T

Thermo Fisher raises profit forecast on strong demand for its tools and services

Thermo Fisher raises profit forecast on strong demand for its tools and services Oct 23 (Reuters) - Thermo Fisher Scientific TMO.N on Wednesday raised the lower end of its annual profit forecast, tweaking it for the third time this year, betting on improved demand for its tools and services used in drug development. Contract drug manufacturers witnessed reduced spending from biotech clients last year, but recent interest cuts could improve the funding environment for biotechs as borrowing costs
T

Dollar rides rising yields, Canada set to ease

MORNING BID AMERICAS-Dollar rides rising yields, Canada set to ease A look at the day ahead in U.S. and global markets from Mike Dolan The dollar continues to ride higher on the back of an anxious pre-election climb in U.S. Treasury yields, notching its best levels in almost three months against the euro and yen on starkly contrasting economic and interest rate pictures.
A
B
E
I
M
N
T
U
L
L
J
U
U
U
T
A
U

Thermo Fisher Q3 Adjusted EPS USD 5.28 Vs. IBES Estimate USD 5.25

BRIEF-Thermo Fisher Q3 Adjusted EPS USD 5.28 Vs. IBES Estimate USD 5.25 Oct 23 (Reuters) - Thermo Fisher Q3 EPS USD 4.25. Q3 adjusted net income USD 2,026 million vs. IBES estimate USD 2,007 million Q3 adjusted EBIT USD 2,362 million vs. IBES estimate USD 2,370 million Q3 revenue USD 10,598 million vs. IBES estimate USD 10,638 million outlook FY ad
T

What to Watch in the Day Ahead - Wednesday, October 23

What to Watch in the Day Ahead - Wednesday, October 23 The Day Ahead is an email and PDF publication that includes the day's major stories and events, analyses and other features. To receive The Day Ahead, Eikon users can register at DAY/US . Thomson One users can register at RT/DAY/US. All times in ET/GMT Wall Street expects Tesla to post a 9% rise in quarterly revenue when the electric vehicle maker reports third-quarter results.
A
B
C
C
D
M
R
T
U
C
T
S
T
R

Thermo Fisher Scientific Inc <TMO.N> expected to post earnings of $5.25 a share - Earnings Preview

Thermo Fisher Scientific Inc expected to post earnings of $5.25 a share - Earnings Preview Thermo Fisher Scientific Inc TMO.N , TMO is expected to show a rise in quarterly revenue when it reports results on October 23 for the period ending September 30 2024 The Waltham Massachusetts-based company is expected to report a 0.6% increase in revenue to $10.638 billion from $10.57 billion a year ago, according to the mean estimate from 21 analysts, based on LSEG data.
T

US FDA Approves Based Companion Diagnostic For First Targeted Therapy For Patients With Grade 2 Mutant Glioma

BRIEF-US FDA Approves NGS-Based Companion Diagnostic For First Targeted Therapy For Patients With Grade 2 IDH-Mutant Glioma Oct 21 (Reuters) - Thermo Fisher Scientific Inc TMO.N : THERMO FISHER SCIENTIFIC: FDA APPROVES NGS-BASED COMPANION DIAGNOSTIC FOR FIRST TARGETED THERAPY FOR PATIENTS WITH GRADE 2 IDH-MUTANT GLIOMA Source text for Eikon: ID:nBw
T

U.S. STOCKS Avery Dennison, Snap-On, Avadel Pharma

BUZZ-U.S. STOCKS ON THE MOVE-Avery Dennison, Snap-On, Avadel Pharma Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street gained on Thursday, with the S&P 500 and the Dow touching intraday record highs, driven by TSMC's upbeat forecast and a bigger-than-expected rise in monthly retail sales indicating a strong U.S.
A
B
C
E
I
N
N
R
S
S
S
U
U
U
U
T
U
W
W
A
E
M
S

U.S. STOCKS PPG Industries, Travelers, ShiftPixy

BUZZ-U.S. STOCKS ON THE MOVE-PPG Industries, Travelers, ShiftPixy Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock indexes were set to rise on Thursday, with an upbeat forecast from TSMC boosting semiconductor stocks, while a bigger-than-expected rise in September retail sales pointed to a strong U.S.
A
A
B
C
C
E
I
N
R
S
U
U
S
T
U
W
W
P
R

US life sciences firms get lift from Sartorius' results

BUZZ-US life sciences firms get lift from Sartorius' results ** Shares of US life sciences firms rise after German peer Sartorius's SATG.DE better-than-expected bioprocessing order intake in its nine-month results ** Premarket, Danaher DHR.N up 3.4%, Thermo Fisher Scientific TMO.N up 2.1% and Waters WAT.N up 1.7% ** Sartorius' order intake rose 6.6
T
W

U.S. STOCKS Wave Life Sciences, Dominion Energy, Voyager Therapeutics

BUZZ-U.S. STOCKS ON THE MOVE-Wave Life Sciences, Dominion Energy, Voyager Therapeutics Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The S&P 500 and the Nasdaq were little changed on Wednesday, with declines in heavily weighted technology megacaps limiting gains as investors turned to small-cap and financial stocks after a slew of upbeat bank earnings.
A
A
I
J
S
U
U
G
T
W
A



Các điều kiện

Các tài sản phổ thông

Khước từ trách nhiệm: các tổ chức thuộc XM Group chỉ cung cấp dịch vụ khớp lệnh và truy cập Trang Giao dịch trực tuyến của chúng tôi, cho phép xem và/hoặc sử dụng nội dung có trên trang này hoặc thông qua trang này, mà hoàn toàn không có mục đích thay đổi hoặc mở rộng. Việc truy cập và sử dụng như trên luôn phụ thuộc vào: (i) Các Điều kiện và Điều khoản; (ii) Các Thông báo Rủi ro; và (iii) Khước từ trách nhiệm toàn bộ. Các nội dung như vậy sẽ chỉ được cung cấp dưới dạng thông tin chung. Đặc biệt, xin lưu ý rằng các thông tin trên Trang Giao dịch trực tuyến của chúng tôi không phải là sự xúi giục, mời chào để tham gia bất cứ giao dịch nào trên các thị trường tài chính. Giao dịch các thị trường tài chính có rủi ro cao đối với vốn đầu tư của bạn.

Tất cả các tài liệu trên Trang Giao dịch trực tuyến của chúng tôi chỉ nhằm các mục đích đào tạo/cung cấp thông tin và không bao gồm - và không được coi là bao gồm - các tư vấn tài chính, đầu tư, thuế, hoặc giao dịch, hoặc là một dữ liệu về giá giao dịch của chúng tôi, hoặc là một lời chào mời, hoặc là một sự xúi giục giao dịch các sản phẩm tài chính hoặc các chương trình khuyến mãi tài chính không tự nguyện.

Tất cả nội dung của bên thứ ba, cũng như nội dung của XM như các ý kiến, tin tức, nghiên cứu, phân tích, giá cả, các thông tin khác hoặc các đường dẫn đến trang web của các bên thứ ba có trên trang web này được cung cấp với dạng "nguyên trạng", là các bình luận chung về thị trường và không phải là các tư vấn đầu tư. Với việc các nội dung đều được xây dựng với mục đích nghiên cứu đầu tư, bạn cần lưu ý và hiểu rằng các nội dung này không nhằm mục đích và không được biên soạn để tuân thủ các yêu cầu pháp lý đối với việc quảng bá nghiên cứu đầu tư này và vì vậy, được coi như là một tài liệu tiếp thị. Hãy chắc chắn rằng bạn đã đọc và hiểu Thông báo về Nghiên cứu Đầu tư không độc lập và Cảnh báo Rủi ro tại đây liên quan đến các thông tin ở trên.

Cảnh báo rủi ro: Vốn của bạn bị rủi ro. Các sản phẩm có đòn bẩy có thể không phù hợp với tất cả mọi người. Hãy xem kỹ Thông báo rủi ro của chúng tôi.